Chengdu Suncadia Medicine Co., Ltd. clinical trials

A subsidiary of Jiangsu HengRui Medicine Co., Ltd.

The registry lists 22 studies whose lead sponsor is Chengdu Suncadia Medicine Co., Ltd.. 6 are recruiting or about to start. Per ClinicalTrials.gov, last updated Sep 28, 2026.

Studies

Recruiting first, then most recently updated. Showing 22 of 22. All Jiangsu HengRui Medicine Co., Ltd. studies →

• A Trial to Evaluate the Long-term Safety and Tolerability of HRS-5965 in Patients With Primary IgA NephropathyRecruitingNCT07582133Phase 2

  Sponsor listed in the registry: Chengdu Suncadia Medicine Co., Ltd.

• A Clinical Study of HRS-8797 in Healthy ParticipantsNot yet recruitingNCT07698756Phase 1

  Sponsor listed in the registry: Chengdu Suncadia Medicine Co., Ltd.

• Phase I Study of HRS-1635 in B-cell MalignanciesRecruitingNCT07583212Phase 1

  Sponsor listed in the registry: Chengdu Suncadia Medicine Co., Ltd.

• A Clinical Trial of HRS-3095 in Patients With Chronic Spontaneous UrticariaNot yet recruitingNCT07613866Phase 2

  Sponsor listed in the registry: Chengdu Suncadia Medicine Co., Ltd.

• A Clinical Study of HRS-5765 in Healthy ParticipantsRecruitingNCT07551167Phase 1

  Sponsor listed in the registry: Chengdu Suncadia Medicine Co., Ltd.

• A Trial of HRS-5965 Capsule in Primary IgA NephropathyRecruitingNCT07014826Phase 3

  Sponsor listed in the registry: Chengdu Suncadia Medicine Co., Ltd.

• The Safety and Efficacy of HR19034 in Children With MyopiaCompletedNCT07844356Phase 2/3

  Sponsor listed in the registry: Chengdu Suncadia Medicine Co., Ltd.

• A Trial of HRS-5965 Tablets in Primary IgA NephropathyCompletedNCT06137768Phase 2

  Sponsor listed in the registry: Chengdu Suncadia Medicine Co., Ltd.

• A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Food Effect of Single and Multiple Doses of HRS-3095 Oral Administration in Healthy Subjects, as Well as the Effect of HRS-3095 on CYP3A4 Metabolic EnzymesCompletedNCT07230418Phase 1

  Sponsor listed in the registry: Chengdu Suncadia Medicine Co., Ltd.

• Investigation of Pharmacokinetics,Safety,and Pharmacodynamics of HRS-5965 in Subjects With Hepatic ImpairmentCompletedNCT06674915Phase 1

  Sponsor listed in the registry: Chengdu Suncadia Medicine Co., Ltd.

• Efficacy and Safety of HRS-5965 in Patients With PNH Who Are Still Anemia After Anti-C5 Antibody TreatmentCompletedNCT06715943Phase 3

  Sponsor listed in the registry: Chengdu Suncadia Medicine Co., Ltd.

• Long-term Safety and Tolerability of HRS-5965 in Patients With Paroxysmal Nocturnal HemoglobinuriaActive, not recruitingNCT06238544Phase 2

  Sponsor listed in the registry: Chengdu Suncadia Medicine Co., Ltd.

• Comparison of HRS-5965 Capsules and Tablets in Healthy SubjectsCompletedNCT06490991Phase 1

  Sponsor listed in the registry: Chengdu Suncadia Medicine Co., Ltd.

• A Study to Evaluate the Efficacy and Safety of Oral HRS-5965 in Adult Paroxysmal Nocturnal Hemoglobinuria (PNH) Patients Who Are Naive to Complement Inhibitor TherapyCompletedNCT06593938Phase 3

  Sponsor listed in the registry: Chengdu Suncadia Medicine Co., Ltd.

• Investigation of Drug-drug Interaction of HRS-5965 With Clopidogrel and Clarithromycin in Healthy SubjectsCompletedNCT07040787Phase 1

  Sponsor listed in the registry: Chengdu Suncadia Medicine Co., Ltd.

• A Clinical Study to Evaluate the Effect of Food on the Pharmacokinetic Profiles of HRS-5965 Capsules in Healthy SubjectsCompletedNCT07035665Phase 1

  Sponsor listed in the registry: Chengdu Suncadia Medicine Co., Ltd.

• A Safety, Tolerability, Pharmacokinetic/Pharmacodynamic Study, and QT Interval Study of HRS-5965 Capsules in Healthy SubjectsCompletedNCT06684041Phase 1

  Sponsor listed in the registry: Chengdu Suncadia Medicine Co., Ltd.

• A Phase II Clinical Study of the Efficacy and Safety of HRS9950 Tablets in Chronic Hepatitis B Patients Who Are Virologically Suppressed on Nucleoside or Nucleotide Analogues (NAs)CompletedNCT05905458Phase 2

  Sponsor listed in the registry: Chengdu Suncadia Medicine Co., Ltd.

• Study of HRS-5965 in Healthy Subjects and Subjects With Renal InsufficiencyCompletedNCT05505955Phase 1

  Sponsor listed in the registry: Chengdu Suncadia Medicine Co., Ltd.

• A Study to Evaluate the Mass Balance of [14C] HRS-5965 in Healthy Adult Male VolunteersCompletedNCT06567392Phase 1

  Sponsor listed in the registry: Chengdu Suncadia Medicine Co., Ltd.

• Proof of Concept Study to Assess the Efficacy, Safety of HRS-5965 in Patients With Paroxysmal Nocturnal HemoglobinuriaCompletedNCT06051357Phase 2

  Sponsor listed in the registry: Chengdu Suncadia Medicine Co., Ltd.

• A Study to Assess the Efficacy and Safety of Paricalcitol in the Treatment of Chronic Kidney Disease With Secondary HyperparathyroidismStatus unknownNCT04994080Phase 3

  Sponsor listed in the registry: Chengdu Suncadia Medicine Co., Ltd.